Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Home
Dr. Carlos Pavesio
Dr. Carlos Pavesio
26 Feb 2018
Share:
More great content like this
- straight to your inbox >
Related To This Subject
Neurology
12th
May
The American Medical Journal Editorial Board
Neurology
12th
May
Dr Rajiv R. Ratan
More articles
Neurology
4
Mins
19 Dec 2025
Brivaracetam in the Real World: Tackling Unmet Needs in FOS
General Healthcare
19 Dec 2025
Unwrap the Best of Healthcare Quiz 2025
Dermatology
8
Mins
16 Dec 2025
Value of Achieving Minimal Disease Activity in Atopic Dermatitis
Featured journals
Dermatology
December 2025
AMJ Dermatology 2 [Supplement 6] 2025
Neurology
December 2025
EMJ Neurology 13 [Supplement 11] 2025
We’ve noticed you’re accessing
from
North/South America.
View
View
